UPPER RESP TRACT INFECTION
Clinical trials for UPPER RESP TRACT INFECTION explained in plain language.
Never miss a new study
Get alerted when new UPPER RESP TRACT INFECTION trials appear
Sign up with your email to follow new studies for UPPER RESP TRACT INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cold virus drug prevent COPD Flare-Ups?
Disease control CompletedThis study tested whether the drug vapendavir can reduce breathing problems in people with COPD who catch a rhinovirus (common cold). Fifty-two adults with COPD were given either vapendavir or a placebo after being exposed to the virus. The main goal was to see if vapendavir lowe…
Matched conditions: UPPER RESP TRACT INFECTION
Phase: PHASE2 • Sponsor: Altesa Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Which cough syrup works best? new study puts three popular options to the test
Symptom relief CompletedThis completed trial tested three common cough treatments—levodropropizine, a codeine combination, and ivy leaf extract—against a placebo in 196 adults with acute cough from upper respiratory infections. Participants took the medicine three times a day for four days. The main goa…
Matched conditions: UPPER RESP TRACT INFECTION
Phase: PHASE4 • Sponsor: Pontificia Universidad Catolica de Chile • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC